Research discovery, development and evaluation
Learn how the CTRND's research impacts central nervous system conditions.
Research Focus Areas
Alzheimer’s Disease (AD) is the most common cause of dementia in the elderly; beginning with subtle memory loss and progressing relentlessly. AD ultimately involves higher cognitive functions, leading to complete incapacitation and death.
Amyotrophic Lateral Sclerosis, also known as ALS or Lou Gehrig’s disease, is a neurodegenerative disease which causes the loss of nerve cells in the brain and spinal cord.
Frontotemporal Lobar Degeneration (FTLD) is a family of disorders that also included Pick’s Disease and frontotemporal dementia (FTD) with amyotrophic lateral sclerosis (ALS or Lou Gehrig’s Disease).
Parkinson’s disease is one of the most common neurodegenerative diseases, second only to Alzheimer’s disease. It is estimated that over 4 million individuals worldwide suffer from the disease, and based on current estimates of its incidence and our growing aging population, that figure will likely double by 2030.
Stroke is the third-leading cause of death in the U.S. (No. 1 in Portugal and in Asia) and the primary cause of adult disability. Stroke accounts for 1 of every 18 deaths in the U.S.
Resources & Technology
We hope that many people who understand the importance of research are able to help future research efforts by agreeing to donate their brain after they die. The generous gift of brain donation helps researchers to understand the disease changes and determine effectiveness of therapies on the disease process.This allows people to contribute for many years after their death.
The CTRND is home to state-of-the-art, leading-edge equipment to assist our researchers with their investigations into the core biological processes of neurodegenerative disease.